Karen A. Foster Biolife Solutions Inc (BLFS) insider trading activity

BLFS Quotes by TradingView

Karen A. Foster is Chief Quality and Operations of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 157,291 shares of BLFS, which is worth approximately $3.68 Million. The most recent transaction as insider was on Aug 27, 2023, when has been sold 403 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 157K
0.41% 3M change
25.48% 12M change
Total Value Held $3.68 Million

Karen A. Foster Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 27 2023
BUY
Grant, award, or other acquisition
-
403 Added 0.32%
124,745 Common Stock
Aug 25 2023
SELL
Open market or private sale
$4,505 $10.99 p/Share
410 Reduced 0.33%
124,342 Common Stock
Aug 14 2023
SELL
Open market or private sale
$1,931 $12.38 p/Share
156 Reduced 0.12%
124,752 Common Stock
Jun 27 2023
SELL
Open market or private sale
$13,516 $22.91 p/Share
590 Reduced 0.47%
124,908 Common Stock
May 31 2023
SELL
Open market or private sale
$9,098 $23.21 p/Share
392 Reduced 0.31%
125,498 Common Stock
May 15 2023
SELL
Open market or private sale
$1,983 $18.71 p/Share
106 Reduced 0.08%
125,890 Common Stock
Apr 06 2023
SELL
Open market or private sale
$22,053 $20.03 p/Share
1,101 Reduced 0.9%
121,839 Common Stock
Mar 29 2023
SELL
Open market or private sale
$8,041 $20.62 p/Share
390 Reduced 0.32%
122,940 Common Stock
Mar 07 2023
SELL
Open market or private sale
$4,016 $22.95 p/Share
175 Reduced 0.14%
123,330 Common Stock
Mar 01 2023
SELL
Open market or private sale
$27,368 $22.75 p/Share
1,203 Reduced 0.96%
123,505 Common Stock
Feb 09 2023
SELL
Open market or private sale
$1,992 $24.6 p/Share
81 Reduced 0.06%
124,708 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
16,978 Added 11.98%
124,789 Common Stock
Dec 28 2022
SELL
Open market or private sale
$10,224 $16.9 p/Share
605 Reduced 0.56%
107,811 Common Stock
Nov 29 2022
SELL
Open market or private sale
$6,118 $19.93 p/Share
307 Reduced 0.28%
108,416 Common Stock
Nov 10 2022
SELL
Open market or private sale
$2,107 $23.16 p/Share
91 Reduced 0.08%
108,723 Common Stock
Sep 29 2022
SELL
Open market or private sale
$12,868 $23.02 p/Share
559 Reduced 0.51%
108,814 Common Stock
Aug 31 2022
SELL
Open market or private sale
$7,009 $23.44 p/Share
299 Reduced 0.27%
109,373 Common Stock
Aug 14 2022
BUY
Grant, award, or other acquisition
-
278 Added 0.25%
109,672 Common Stock
Aug 10 2022
SELL
Open market or private sale
$2,201 $23.17 p/Share
95 Reduced 0.09%
109,394 Common Stock
Jul 29 2022
BUY
Grant, award, or other acquisition
-
355 Added 0.32%
109,489 Common Stock
Jul 17 2022
BUY
Grant, award, or other acquisition
-
430 Added 0.39%
109,134 Common Stock
Jul 03 2022
BUY
Grant, award, or other acquisition
-
468 Added 0.43%
108,704 Common Stock
Jun 28 2022
SELL
Open market or private sale
$8,886 $14.86 p/Share
598 Reduced 0.55%
108,236 Common Stock
Jun 19 2022
BUY
Grant, award, or other acquisition
-
497 Added 0.45%
108,834 Common Stock
Jun 05 2022
BUY
Grant, award, or other acquisition
-
498 Added 0.46%
108,337 Common Stock
KAF

Karen A. Foster

Chief Quality and Operations
Bothell, WA

Track Institutional and Insider Activities on BLFS

Follow BIOLIFE SOLUTIONS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

News

Receive news related to BIOLIFE SOLUTIONS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BLFS